JP4891125B2 - 抗ｃｄ１４抗体融合蛋白質 - Google Patents

抗ｃｄ１４抗体融合蛋白質 Download PDF

Info

Publication number
JP4891125B2
JP4891125B2 JP2007076890A JP2007076890A JP4891125B2 JP 4891125 B2 JP4891125 B2 JP 4891125B2 JP 2007076890 A JP2007076890 A JP 2007076890A JP 2007076890 A JP2007076890 A JP 2007076890A JP 4891125 B2 JP4891125 B2 JP 4891125B2
Authority
JP
Japan
Prior art keywords
amino acid
uti
acid sequence
seq
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007076890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007215546A5 (enExample
JP2007215546A (ja
Inventor
正司 古迫
和行 中山
義隆 保坂
哲史 川原
正樹 中村
隆志 武内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP2007076890A priority Critical patent/JP4891125B2/ja
Publication of JP2007215546A publication Critical patent/JP2007215546A/ja
Publication of JP2007215546A5 publication Critical patent/JP2007215546A5/ja
Application granted granted Critical
Publication of JP4891125B2 publication Critical patent/JP4891125B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2007076890A 2005-06-03 2007-03-23 抗ｃｄ１４抗体融合蛋白質 Expired - Fee Related JP4891125B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007076890A JP4891125B2 (ja) 2005-06-03 2007-03-23 抗ｃｄ１４抗体融合蛋白質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005164901 2005-06-03
JP2005164901 2005-06-03
JP2007076890A JP4891125B2 (ja) 2005-06-03 2007-03-23 抗ｃｄ１４抗体融合蛋白質

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006551131A Division JP4067557B2 (ja) 2005-06-03 2006-06-05 抗ｃｄ１４抗体融合蛋白質

Publications (3)

Publication Number Publication Date
JP2007215546A JP2007215546A (ja) 2007-08-30
JP2007215546A5 JP2007215546A5 (enExample) 2009-07-16
JP4891125B2 true JP4891125B2 (ja) 2012-03-07

Family

ID=38493452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007076890A Expired - Fee Related JP4891125B2 (ja) 2005-06-03 2007-03-23 抗ｃｄ１４抗体融合蛋白質

Country Status (1)

Country Link
JP (1) JP4891125B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3112463B1 (en) 2014-02-26 2019-09-04 Mochida Pharmaceutical Co., Ltd. Novel anti-presepsin antibody

Also Published As

Publication number Publication date
JP2007215546A (ja) 2007-08-30

Similar Documents

Publication Publication Date Title
JP4067557B2 (ja) 抗ｃｄ１４抗体融合蛋白質
DK2222707T3 (en) Monoclonal anti-factor XI antibodies and method of use thereof
CN101253264B (zh) 抗血小板膜糖蛋白ⅵ单克隆抗体
ES2364266T3 (es) Anticuerpo humanizado hacia el factor tisular humano (tf) y procedimiento para construir el anticuerpo humanizado.
US20060159675A1 (en) Compositions and methods for treating coagulation related disorders
RU2758160C2 (ru) Новые антитела против фактора xi и их применения
JP2023139243A (ja) 抗ペリオスチン抗体及びその使用
WO2006118350A1 (ja) 抗血小板膜糖蛋白質ⅵモノクローナル抗体
AU2017265172B2 (en) Anti-factor xi monoclonal antibodies and methods of use thereof
RU2741802C2 (ru) АНТИТЕЛО К Myl9
JP6895884B2 (ja) 肺高血圧症の治療薬及び治療方法
JP4891125B2 (ja) 抗ｃｄ１４抗体融合蛋白質
CA3206789A1 (en) Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19
HK1223114B (en) Anti-factor xi monoclonal antibodies and methods of use thereof

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090603

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A132

Effective date: 20110920

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111213

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111215

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141222

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees